Construction and Validation of a Metastasis-Related Prognostic Model for Hepatocellular Carcinoma Patients

被引:0
|
作者
Liu Y. [1 ,2 ]
Xiong R. [2 ,3 ]
Xiao T. [2 ,3 ]
Yang Y. [4 ]
Liu K. [2 ]
Feng G. [2 ]
Song G. [1 ,2 ]
机构
[1] School of Basic Medicine, North Sichuan Medical College, Nanchong
[2] Institute of Tissue Engineering and Stem Cells, The Second Clinical Medical College of North Sichuan Medical College, Nanchong Central Hospital, Nanchong
[3] School of Medical Imaging, North Sichuan Medical College, Nanchong
[4] Sichuan Chidingshengtong Biotechnology Co., Ltd, Chengdu
关键词
Hepatocellular carcinoma; Metastasis-related genes; Prognostic model; Validation;
D O I
10.12178/1001-0548.2021301
中图分类号
学科分类号
摘要
Hepatocellular carcinoma is a malignant tumor with high aggressiveness and metastasis. This study aims to construct a predictive model based on metastasis-related genes (MTGs). Cox analysis and Lasso regression analysis were used to build the prognostic model, and the relationship between the risk score of this model and the survival and clinical characteristics of hepatocellular carcinoma (HCC) patients was analyzed. The results of the study constructed a prognostic model containing four MTGs. In the the cancer genome atlas (TCGA) training set, HCC patients in the low-risk group had lower risk scores, fewer deaths and higher 5-year survival (P < 0.01), Cox analysis showed that the model could predict survival of HCC patients independently of other clinical characteristics ( P < 0.01), and the AUC values of 1-, 2- and 3-years were all greater than 0.74 in the time-dependent ROC curve prediction analysis. Meanwhile, the validation set also confirmed the above results. Taken together, we constructed a MTGs prognostic model and it was expected to be an independent prognostic factor for prognostic prediction judgment of HCC patients. Copyright ©2022 Journal of University of Electronic Science and Technology of China. All rights reserved.
引用
收藏
页码:184 / 193
页数:9
相关论文
共 31 条
  • [21] YANG S W, JI Q H, CHANG B, Et al., STC2 promotes head and neck squamous cell carcinoma metastasis through modulating the PI3K/AKT/Snail signaling, Oncotarget, 8, 4, pp. 5976-5991, (2017)
  • [22] CHEN B, ZENG X, HE Y, Et al., STC2 promotes the epithelial-mesenchymal transition of colorectal cancer cells through AKT-ERK signaling pathways, Oncotarget, 7, 44, pp. 71400-71416, (2016)
  • [23] BI Y Q, CHEN S, JIANG J Z, Et al., CDCA8 expression and its clinical relevance in patients with bladder cancer, Medicine (Baltimore), 97, 34, (2018)
  • [24] CI C, TANG B, LYU D, Et al., Overexpression of CDCA8 promotes the malignant progression of cutaneous melanoma and leads to poor prognosis, Int J Mol Med, 43, 1, pp. 404-412, (2019)
  • [25] HAYAMA S, DAIGO Y, YAMABUKI T, Et al., Phosphorylation and activation of cell division cycle associated 8 by aurora kinase B plays a significant role in human lung carcinogenesis, Cancer Res, 67, 9, pp. 4113-4122, (2007)
  • [26] DING X S, HUANG R H, ZHONG Y M, Et al., CTHRC1 promotes gastric cancer metastasis via HIF-1alpha/CXCR4 signaling pathway, Biomed Pharmacother, 123, (2020)
  • [27] LI L Y, YIN K M, BAI Y H, Et al., CTHRC1 promotes M2-like macrophage recruitment and myometrial invasion in endometrial carcinoma by integrin-Akt signaling pathway, Clin Exp Metastasis, 36, 4, pp. 351-363, (2019)
  • [28] LI N, CHEN L C, LIU C Y, Et al., Elevated CTHRC1 expression is an indicator for poor prognosis and lymph node metastasis in cervical squamous cell carcinoma, Hum Pathol, 85, pp. 235-241, (2019)
  • [29] NI S J, REN F, XU M D, Et al., CTHRC1 overexpression predicts poor survival and enhances epithelial-mesenchymal transition in colorectal cancer, Cancer Med, 7, 11, pp. 5643-5654, (2018)
  • [30] GUO B Y, YAN H, LI L Y, Et al., Collagen triple helix repeat containing 1 (CTHRC1) activates Integrin beta3/FAK signaling and promotes metastasis in ovarian cancer, J Ovarian Res, 10, 1, (2017)